K

R

Redalpine

Crunchbase
Pitchbook
Crunchbase

Deals on record

9

Common Fundraising Type

Equity

V
Voize

AI • Speech recognition

Y Combinator logo
HV Capital logo
redalpine logo
HPI Ventures logo

Voize is an AI startup that develops speech recognition technology to streamline healthcare documentation by allowing caregivers to dictate notes into smartphones, which the AI processes into structured documentation.

Seed
$9M
03/31/2025
Article
L
Level Zero Health

Wearable device • Hormone monitoring

redalpine logo
SOSV logo
Entrepreneur First logo

Level Zero Health is a healthtech startup developing a wearable device for continuous hormone monitoring using DNA-based sensors.

Seed
$6.9M
02/18/2025
Article
9
9fin

Fintech • Debt market data

Highland Europe logo
Spark Capital logo
Seedcamp logo
Redalpine logo

9fin is a fintech startup that provides debt market data and analytics services to major investment banks.

Series B
$50M
12/02/2024
Article
A
Apaleo

API-first • Open platform

Rockaway Ventures logo
Redalpine logo
PSG Equity logo
FOMCAP IV logo

Apaleo provides an API-first open property management platform for managing hospitality properties globally.

Equity
$21.1M
11/21/2024
Article
D
Dunia.ai

AI-driven • Material discovery

redalpine logo
Elaia logo
Pace Ventures logo
Kindred Capital logo

Dunia Innovations is a deeptech startup that uses AI-driven material discovery and a self-driving lab to accelerate the development of advanced materials for green hydrogen, ammonia production, and CO2 conversion.

Equity
$11.5M
10/23/2024
Article
B
Basecamp Research

AI platform • Biological insights

S32 logo
Singular logo
redalpine logo

Basecamp Research is a London-based startup developing an AI platform for biological insights by building a comprehensive database of primary-source biological data for applications in drug discovery and genetic medicine.

Series B
$60M
10/09/2024
Article
M
Memo Therapeutics

Biotech • Late-Stage

Vesalius Biocapital logo
Verve Ventures logo
Swisscanto logo
Schroders Capital logo

Memo Therapeutics is a late-stage biotech company that has raised CHF 25M in a Series C funding round to develop its antibody, AntiBKV, and advance its existing antibody pipeline.

Series C
$27.6M
11/02/2023
Article
U
Umiami

Plant-based meat alternatives • Food tech

Verso Capital logo
Redalpine logo
Newfund logo
KIMA Ventures logo

Umiami is a Paris-based food tech company that specializes in plant-based meat alternatives and aims to reduce the environmental impact of livestock farming and improve animal welfare and human health, and they have recently raised $34.7 million in funding to accelerate their technology industrialization, expand in the American market, and continue their expansion in Europe.

Equity
$34.7M
10/20/2023
Article
L
Lakera

Cybersecurity • Artificial Intelligence

Redalpine logo
Inovia Capital logo
Fly Ventures logo

Lakera is a Swiss startup that protects enterprises from security weaknesses in large language models by developing a database of insights from linguistic trickery and interactive games, allowing them to categorize types of attacks and address misinformation or factual inaccuracies.

Equity
$10M
10/12/2023
Article